Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease - an Observational Study
WARD-COPD
Continuous Vital Sign Monitoring During Admission for Acute Exacerbations of Chronic Obstructive Pulmonary Disease - an Observational Study
1 other identifier
observational
200
1 country
2
Brief Summary
For patients admitted to the medical ward, it is often difficult to predict if their clinical condition will deteriorate, however subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The WARD-COPD project aims to determine the correlation between cardiopulmonary micro events and clinical adverse events during the first four days after hospital admission with acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2018
CompletedFirst Posted
Study publicly available on registry
September 6, 2018
CompletedStudy Start
First participant enrolled
September 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2020
CompletedAugust 27, 2020
August 1, 2020
1.3 years
September 4, 2018
August 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Any serious adverse events
E.g. cardiac arrest, ICU admission, acute myocardial infarction, stroke, sepsis, acute kidney injury or other serious adverse events (defined in Protocol Appendix A)
within 30 days after inclusion
Secondary Outcomes (2)
Mortality
within 6 months after inclusion
Readmission
within 6 months after inclusion
Interventions
Patients recruited will be continuously monitored with Isansys Lifetouch patch, Isansys wireless blood pressure monitor, Nonin WristOx 3150, Empatica E4, and Radiometer TCM5 FLEX monitor.
Eligibility Criteria
200 patients admitted to hospital with acute exacerbation of COPD will be included in the study upon arrival to the medical ward.
You may qualify if:
- Adult patients admitted with AECOPD
- Recruitment and monitoring start is possible within 24 hours after admission
You may not qualify if:
- Patient expected not to cooperate
- Patient allergic to plaster, plastic or silicone
- Active therapy withdrawn
- Patients with dementia or not able to give informed consent
- Patients with pacemaker or implantable cardioverter-defibrillator (ICD) unit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Bispebjerg and Frederiksberglead
- Technical University of Denmarkcollaborator
- Herlev and Gentofte Hospitalcollaborator
Study Sites (2)
Bispebjerg Hospital
Copenhagen, 2400, Denmark
Gentofte Hospital
Hellerup, 2900, Denmark
Related Publications (1)
Elvekjaer M, Rasmussen SM, Gronbaek KK, Porsbjerg CM, Jensen JU, Haahr-Raunkjaer C, Molgaard J, Sogaard M, Sorensen HBD, Aasvang EK, Meyhoff CS. Clinical impact of vital sign abnormalities in patients admitted with acute exacerbation of chronic obstructive pulmonary disease: an observational study using continuous wireless monitoring. Intern Emerg Med. 2022 Sep;17(6):1689-1698. doi: 10.1007/s11739-022-02988-w. Epub 2022 May 20.
PMID: 35593967DERIVED
Biospecimen
Troponin, Arterial Blood Gas
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Christian Meyhoff, MD, PHD
Bispebjerg and Frederiksberg Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 4, 2018
First Posted
September 6, 2018
Study Start
September 12, 2018
Primary Completion
December 21, 2019
Study Completion
June 21, 2020
Last Updated
August 27, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share